E-LIB Suche - Ergebnisse für: Zhu, Chengpei

1

Conversion surgery intervention versus continued systemic t..:

Wang, Shanshan ; Wang, Yunchao ; Zhu, Chengpei...
International Journal of Surgery. , 2024

Link: https://doi.org/10.1097/..

2

Editorial: Advances in immunotherapy and combination therap..:

Zhu, Chengpei ; Robson, Simon C. ; Sun, Huichuan.
Frontiers in Oncology. 13 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Lenvatinib combined with PD-1 inhibitor plus Gemox chemothe..:

Zhang, Ting ; Zhu, Chengpei ; Zhang, Nan...
International Immunopharmacology. 129 (2024) - p. 111642 , 2024

Link: https://doi.org/10.1016/..

4

Radiation Therapy With Combination Therapy of Immune Checkp..:

Ning, Cong ; Zhang, Xinmu ; Wang, Yanyu...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. 1461-1471 , 2024

Link: https://doi.org/10.1016/..

5

Efficacy, safety, and prognostic factors of PD-1 inhibitors..:

Zhu, Chengpei ; Li, Hu ; Yang, Xiaobo...
Cancer Immunology, Immunotherapy. 72 (2023) 9 - p. 2949-2960 , 2023

Link: https://doi.org/10.1007/..

6

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 ..:

Zhu, Chengpei ; Xue, Jingnan ; Wang, Yunchao...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Effectiveness and safety of radiotherapy plus programmed de..:

Wang, Yunchao ; Yang, Xiaobo ; Wang, Yanyu...
Cancer Immunology, Immunotherapy. , 2023

Link: https://doi.org/10.1007/..

8

Real-world cohort study of PD-1 blockade plus lenvatinib fo..:

Chao, Jiashuo ; Wang, Shanshan ; Wang, Hao...
Cancer Immunology, Immunotherapy. 72 (2023) 11 - p. 3717-3726 , 2023

Link: https://doi.org/10.1007/..

9

Safety and feasibility of toripalimab plus lenvatinib with ..:

Wang, Yunchao ; Zhang, Nan ; Xue, Jingnan...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

A novel cuproptosis-related gene signature for overall surv..:

Yang, Fan ; Jiang, Shitao ; Liu, Yaoge...
Heliyon. 8 (2022) 11 - p. e11768 , 2022

Link: https://doi.org/10.1016/..

11

Identification of the molecular relationship between intrav..:

Zhang, Xu ; Wu, Liangcai ; Xu, Rongjian...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

12

The fusion landscape of hepatocellular carcinoma:

Zhu, Chengpei ; Wu, Liangcai ; Lv, Yanling...
Molecular Oncology. 13 (2019) 5 - p. 1214-1225 , 2019

Link: https://doi.org/10.1002/..

13

Gallbladder papillary neoplasms share pathological features..:

Wan, Xueshuai ; Shi, Jie ; Wang, Anqiang...
Oncotarget. 8 (2017) 19 - p. 31532-31539 , 2017

Link: https://doi.org/10.18632..

14

A new avenue for obtaining insight into the functional char..:

Wu, Liangcai ; Xu, Qianqian ; Zhang, Haohai...
Scientific Reports. 6 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

15

MetastamiRs: A promising choice for antihepatocellular carc..:

Wu, Liangcai ; Bai, Xue ; Xie, Yuan...
Hepatology Research. 47 (2016) 1 - p. 80-94 , 2016

Link: https://doi.org/10.1111/..